Articles related to LEUKEMIA

Explore the CML SUN study’s findings, which highlight the unmet need for shared decision-making in the choice of CML treatment—a void that may have an impact on patient satisfaction and treatment outcomes.

Gain insight into how a shift in cellular environment and UV radiation exposure can instigate additional mutations, deepening our understanding of the evolution and development of rare and complex malignancies such as BPDCN.

Discover the potential of pirtobrutinib, a noncovalent BTK inhibitor, in transforming the management of refractory B-cell cancers. Explore the promising results from the recent phase 1-2 trial.

This study demonstrates how pharmacists can improve patient safety and dramatically save costs in the management of chronic myeloid leukemia by highlighting the possibility of pharmacist-led TKI cessation programs.

Discover how a groundbreaking trial using a new CRISPR gene-editing technique has successfully treated a patient with T-cell leukemia, a form of the disease resistant to conventional treatments. Learn how this innovative approach could revolutionize the treatment of various diseases affecting the blood, bone marrow, and immune systems.

Bridging the Gap: Twinning Programs Improve Pediatric Cancer Survival Rates Across Borders In a world where a few miles can determine the fate of a child with cancer, twinning programs are making a significant difference. These initiatives, which pair hospitals across borders, are helping to bridge the survival gap in pediatric acute leukemia between high-income and lower-income countries. Key Points: “There’s no pediatric centers in many of the mountain west states. If your kid gets cancer in Wyoming, you gotta go to Utah or Colorado or Mayo in Minnesota. But here, there’s really nice evidence that providing the right protocols, training, staff, and more, we could do this in more places and improve outcomes without developing a new drug.” Gwen Nichols, chief medical officer of the Leukemia and Lymphoma Society